Why buy toxic assets to rescue financial firms? Why not just inject capital? Some observers are saying that's the better way to go.
See my story, where I mention John Hussman's take on this issue.
Hussman gives an easy example of some balance sheets, showing the difference between removing toxic assets at a low price, vs. simply injecting the same amount into a troubled firm.
No comments:
Post a Comment